Mega Lifesciences Public Company Limited, together with its subsidiaries, manufactures and sells health food supplements, prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods. The company operates through three segments: Brands, Distribution, and Original Equipment Manufacture. It offers wellness and nutrition products, including medical and sports nutrition, general well-being, vitamins, probiotics, herbal medicines, and cough and cold medicines, as well as hair, kid’s, men’s, and women’s care products; and various health concerns products, such as allergy, bone and joint, gut, liver, diabetic, eye, heart, brain, sleep and anxiety, pain, and skin care, as well as blood circulation and memory. The company also provides prescription medicines for anti-allergic, anti-infective, cardiovascular system, central nervous system, dermatology, diabetes, gastrointestinal, gynecology, nephrology, oncology, ophthalmology, orthopedic, pain, respiratory, rheumatology, and urology areas under the MEGA We care brand name. In addition, it offers logistical and marketing services for trading and sale of goods manufactured by third parties comprising warehouse management, collections, and value-added services; natural and plant-based health foods; digital support solutions; and operation of wellness center. Further, the company is involved in social enterprise; and software design, development, and other services. It sells its products in in Southeast Asia, Sub-Saharan Africa, Australia, Europe, and South America. Mega Lifesciences Public Company Limited was incorporated in 1982 and is headquartered in Bangkok, Thailand.
तुलना करने के लिए मीट्रिक्स | MEGA | क्षेत्र सेक्टर - संबंधित क्षेत्र की कंपनियों के व्यापक समूह से मेट्रिक्स का औसत हेल्थकेयर | संबंध संबंधMEGAपीअर्सक्षेत्र | |
|---|---|---|---|---|
पी/ई अनुपात | 16.3x | 22.2x | −0.5x | |
PEG अनुपात | −3.26 | 0.47 | 0.00 | |
क़ीमत/बुक | 3.1x | 2.9x | 2.6x | |
क़ीमत / एलटीएम बिक्री | 2.2x | 3.7x | 3.2x | |
अपसाइड (विश्लेषक लक्ष्य) | 10.5% | 17.2% | 51.4% | |
उचित मूल्य अपसाइड | अनलॉक करें | 12.3% | 8.5% | अनलॉक करें |